leisure time -WSS

leisure time

author：focus 2025-09-29 16:46:07 - browse：99

Garry Tan, CEO of Y Combinator Seb Daly/Web Summi

WASHINGTON — In San Francisco, Y Combinator’s firebrand chief executive Garry Tan is one of the startup economy’s most recognizable figures. Well before he became the leader of the coveted startup accelerator that bred global brands like Airbnb, Stripe and OpenAI, Tan was a self-made founder who sold his own company to Twitter.

But here in the nation’s political capital, Tan is far less known. He’s hoping to grow his influence here, offering up his vast network of founders as a source of expertise for regulators struggling to wrap their heads around new technologies like artificial intelligence and how best to rein it in.

“We’re happy to be a phone-a-friend for people who are trying to understand tech,” he told the Economic Club of Washington recently when asked how he’d measure success during Y Combinator’s first-ever policy-focused visit. “‘Little tech’ represents competition, and consumer choice,” he said later at a separate event in a dimly lit Senate room filled with a few dozen Congressional staffers.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Feds fine Medicare Advantage plans for overcharging members

WSS

ProMED sees offers of support, but its future remains unclear

What AAP's gender

An interview with Robert F. Kennedy Jr. on vaccines

ActiGraph execs on goal of drug approvals with digital endpoints

2024 GOP presidential candidates spar over abortion in debate

Drug firms test therapies to halt Alzheimer’s before symptoms arise

explore

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Peter Hotez and the public health issue of online harassment

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Walensky prepares to leave CDC — and Congress — behind

CDC advisory panel says seniors 'may' get RSV vaccine

Supreme Court strikes down use of affirmative action

Eye stem cell transplant could help restore vision in injured people

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

New definition of a human embryo proposed amid rapid advances

Affirmative action in medical school literally saved lives

As pharma fights Medicare drug negotiation, hospitals, docs silent

leisure time

Radiation, mainstay of cancer treatment, begins a fade

Living with Hashimoto's and celiac disease, and med school, too

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Why more medical students aren't specializing in primary care

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Why more medical students aren't specializing in primary care

knowledge

explore

focus

focus